Bayer Expands Trial for Investigational Menopause Sleep Disturbance Treatment
Bayer is starting a phase II study to evaluate elinzanetant in women with sleep disturbances associated with menopause.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
